.ALPHA.4,.ALPHA.4,.ALPHA.5,.ALPHA.5-TETRAMETHYL-2-PROPYL-1-((2'-(1-(TRIPHENYLMETHYL)-1H-TETRAZOL-5-YL)(1,1'-BIPHENYL)-4-YL)METHYL)-1H-IMIDAZOLE-4,5-DIMETHANOL
UNII 3GAE963S5M
Substance Identification & Data
This profile provides standardized clinical and technical data for .alpha.4,.alpha.4,.alpha.5,.alpha.5-tetramethyl-2-propyl-1-((2'-(1-(triphenylmethyl)-1h-tetrazol-5-yl)(1,1'-biphenyl)-4-yl)methyl)-1h-imidazole-4,5-dimethanol, uniquely identified by the FDA Unique Ingredient Identifier (UNII) 3GAE963S5M.
Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 1418133-29-5 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.
Detailed Substance Profile
C45H46N6O2 HLCZBXRILXLLAC-UHFFFAOYSA-N Synonyms and Nomenclature
This section provides a complete list of nomenclature and identifier mappings for .alpha.4,.alpha.4,.alpha.5,.alpha.5-tetramethyl-2-propyl-1-((2'-(1-(triphenylmethyl)-1h-tetrazol-5-yl)(1,1'-biphenyl)-4-yl)methyl)-1h-imidazole-4,5-dimethanol. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.